The management of NAFLD includes both treating the liver condition as well as the other associated or underlying metabolic disorders like insulin resistance, Type 2 diabetes, obesity and high fat levels in the blood.
NAFLD
The management of NAFLD includes both treating the liver condition as well as the other associated or underlying metabolic disorders like insulin resistance, Type 2 diabetes, obesity and high fat levels in the blood.
The main goal of management of NAFLD is weight loss. Lifestyle modification includes
Dietary modifications with calorie-restricted diet are recommended in patients who are over weight or obese to reduce weight and to improve metabolic disorders.
Daily diet should be calorie deficient for example if a person needs total 2000 calories in day according to his BMI (proportion of weight to height) to sustain day-to-day activities or to maintain weight, the person should consume less than that.
Following a calorie restricted diet over a period will result in
There is no particular diet with particular proportions of macronutrients (carbs, proteins, fats) recommended for weight loss at present. But Mediterranean diet consisting of high amounts of fresh fruits, vegetables, olive oil and low amounts of protein is found to be beneficial in improving the fat content in the liver.
Along with calorie restricted it advised to indulge in physical activity like walking, jogging, swimming and cycling to assist in weight loss and to improve metabolic disorders.
There is no recommended duration and intensity of exercise. But studies have shown that those who maintain a physical activity for more than 150 minutes per week and increase it every week have shown to improve their liver enzymes (ALT and AST) and metabolic disorders regardless of weight loss.
Patients with NAFLD are recommended not to take any alcohol of any type or amount.
Management with medicines is preserved only for NAFLD patients
To prevent outcomes of NAFLD or NASH in the long-term
These are a group of drugs that are aimed at treating insulin resistance and other metabolic disorders associated with glucose and fat metabolism
Patients with NAFLD have dyslipidemia a condition with high triglycerides and abnormal fat levels in blood that can contribute to worsening of NAFLD and increased heart risk. Dyslipidemia in NAFLD patients is treated with a category of drugs called statins that reduce the abnormal fat levels in blood and improve the elevated liver enzymes and reduce heart risks.
Omega-3 fatty acids are not specifically recommended to treat NAFLD or NASH but are considered to treat hypertriglyceridemia (high levels of triglycerides) in patients with NAFLD.
Vitamin E is considered as an anti-oxidant and its administration has shown to improve liver conditions like elevated liver enzymes, fat accumulation, cell death and inflammation of liver in NASH patients without Type 2 diabetes. Risks and benefits are assessed carefully before starting the treatment with Vitamin E. It is to be noted that Vitamin E is not recommended in NAFLD patients without biopsy, NASH patients with diabetes and NASH cirrhosis or cryptogenic cirrhosis.
Bariatric surgery is a type of surgery done to reduce weight by reducing the capacity of food intake.
Advantages of bariatric surgery in NAFLD and NASH patients
Liver transplantation is done only in
Lot of factors like obesity and other associated risk factors like heart and kidney complications are thoroughly studied before the surgery. As most of the NASH patients are severely obese, weight loss through diet and exercise are recommended before the surgery and are recommended to maintain weight after the surgery for improved and sustained outcomes.
Reference:
Chalasani, N. , Younossi, Z. , Lavine, J. E., Charlton, M. , Cusi, K. , Rinella, M. , Harrison, S. A., Brunt, E. M. and Sanyal, A. J. (2018), The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67: 328-357. doi:10.1002/hep.29367